-
Canada: Study Officially Completed
-
Canada: Final Participant Completes 12-Month Follow-Up
-
Canada: Enrollment Concluded
-
Canada: Two More Subjects Treated
-
Canada: Fifth Subject Enrolled
-
Canada: Fourth Subject Enrolled and Treated in Vancouver Study
-
Canada: Third Subject Treated in Vancouver Study
-
Canada: First Subject Treated in Vancouver Study
-
Canada: First Preparatory Session; Second and Third Subjects Enrolled
-
Canada: First Subject Enrolled
-
Canadian Study: Subject Screening Begins
-
Canadian Study: New Co-Investigators Participate in Therapist Training
-
Canada: Institutional Review Board Approves Protocol Amendment
-
Canada: Subject Screening Begins
-
Canadian Study: Health Canada Accepts Protocol Changes; Study Prepares for Subject Screening
-
Canada: Institutional Review Board Approves Amended Study Protocol
-
Canadian Study: Institutional Review Board Approves Amended Study Protocol
-
Canadian Study: Protocol Amendments Submitted to Institutional Review Board
-
Canadian Study: Nine Grams of MDMA Arrive in Canada after Four-Year Delay
-
Canadian Study: Nine Grams of MDMA Arrive in Canada after Four-Year Delay
